Y
ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Geriatrics · Age Ageing · 2026-08-03

In a dose-response meta-analysis of 13 observational studies (7,891,574 adults with overactive bladder), anticholinergic use was associated with higher dementia risk (HR 1.52), rising sharply over the first 3 years and peaking at ~874 cumulative defined daily doses (HR 1.63).

Meta-analysisn = 7,891,574
Kim et al. Nonlinear dose-response relationship between cumulative anticholinergic use and the risk of dementia in adults with overactive bladder: a systematic review and dose-response meta-analysis
Geriatrics · Age Ageing · 2026-08-03

In 47 adults aged ≥70 admitted to an acute geriatric unit, a multicomponent exercise programme (4±2 sessions) improved SPPB at discharge vs usual care (mean difference 3.18 points, 95% CI 1.3 to 5.1); MMSE (secondary) also favoured exercise (2.16 points).

RCTn = 47
Bandeira-Guimarães et al. Preservation of functional capacity and lower-limb mechanical power during acute hospitalisation: effects of a low-cost multicomponent exercise programme in older adults-a randomised controlled trial
Geriatrics · Age Ageing · 2026-08-03

In 25 long-term care residents with severe dementia (19 completed both periods), THC/CBD oil did not reduce agitation (CMAI) versus placebo in a crossover trial. As-needed psychotropic use was lower on THC/CBD, a secondary outcome; no related serious adverse events.

RCTn = 25
Bianchi et al. A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results

Sign in to react

Enter your email and we send a one-time link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.